China Vanke Co Ltd (2202)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 21 Oct 2026
Key indicators
| Last close | HKD 2.325 |
|---|---|
| 52-week range | 2.100 – 5.170 |
| Return, 1 month / 3 months | −1.1% / −3.1% |
| Return, 1 year / 3 years | −55.4% / −73.5% |
| Trend | Below its 200-day average |
| RSI (14) | 40 |
| Volatility (1 year) | 45.5% |
| Worst drawdown (1 year) | -57.9% |
| Average daily value traded | 87.15M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Vanke is a property developer based in Shenzhen that builds and sells homes for urban households across mainland China. Its main business is residential development, including apartment towers and housing estates, alongside related services such as property management for the communities it creates. The company works with homebuyers and also develops commercial and mixed-use projects in Chinese cities, serving customers in the domestic housing market through its development and management operations.
On this site China Vanke Co Ltd appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 2202, with prices in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Vanke Co Ltd (2202) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 2.325 on 21 October 2026.
Its price-based Market X-Ray is 47 out of 100 (a weak price profile), ranking 1,450 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 55.4% and over the last three months it fell 3.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 32 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.2% | ||
| From 52-week high | -53.9% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.1% | ||
| 6-month return | -23.8% | ||
| 12-month return, skipping the last month | -54.9% | ||
| Stability (higher is calmer) | 49 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 45.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.9% | ||
| Liquidity | 90 · Strong | Trades actively. | |
| Average daily value traded | 87.15M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −6.4% |
|---|---|
| 1 month | −1.1% |
| 3 months | −3.1% |
| 6 months | −23.8% |
| 1 year | −55.4% |
| 3 years | −73.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 2.456 / 2.879 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.153 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Jul 2023 | HKD 0.7386 |
| 14 Jul 2022 | HKD 1.1424 |
| 13 Jul 2021 | HKD 1.4999 |
| 16 Jul 2020 | HKD 1.1166 |
| 17 Jul 2019 | HKD 1.1918 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.